[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1, 1983

Progestin Prophylaxis of Osteoporosis

Author Affiliations

Riehen, Switzerland

JAMA. 1983;249(13):1710. doi:10.1001/jama.1983.03330370024020
Abstract

To the Editor.—  I have read the question "Osteoporosis Prophylaxis in a Postmastectomy Patient?" and the two answers in the QUESTIONS AND ANSWERS section (1982;248:1108) and would like to draw attention to the possibility of progestogen prophylaxis of osteoporosis. If estrogens are contraindicated, progestogens alone may prove helpful and should be prescribed for such patients. Norethindrone, 5 mg/day, is recommended by Nordin et al,1 since it has been demonstrated that 5 mg of norethindrone is effective in reducing calcium excretion in the urine.2 Norethindrone or norethindrone acetate has been found useful as endocrine treatment in patients with breast cancer and can, therefore, be prescribed for osteoporosis prophylaxis if considered necessary.

×